Use of belatacept during post depletional repopulation to facilitate tolerance in renal allograft recipients
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Alemtuzumab (Primary) ; Belatacept (Primary) ; Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Proof of concept; Therapeutic Use
- 06 Jun 2018 Long term results presented at the 2018 American Transplant Congress.
- 14 Nov 2017 Results published in the American Journal of Transplantation
- 22 Dec 2015 Planned End Date changed from 1 Dec 2019 to 1 Aug 2019 as per ClinicalTrials.gov record.